world
health
organ
alert
late
march
earli
april
regard
case
human
infect
hemagglutinin
neuraminidas
caus
new
influenza
viru
also
known
swine
flu
pig
influenza
hog
flu
first
detect
mexico
subsequ
case
occur
mani
countri
includ
turkey
order
prevent
pandem
larg
proport
popul
need
acquir
immun
either
vaccin
natur
detect
viru
vaccin
manufactur
start
develop
pandem
vaccin
global
vaccin
inocul
swine
flu
use
inactiv
without
adjuv
live
attenu
vaccin
healthcar
worker
among
first
inocul
swine
flu
countri
includ
turkey
control
epidem
announc
vaccin
produc
start
make
deliveri
autumn
northern
hemispher
report
media
internet
indic
health
worker
unwil
receiv
swine
flu
vaccin
occasion
vaccin
produc
gener
sideeffect
red
allergi
swell
headach
muscl
ach
pain
swell
site
inject
mild
rash
fever
last
common
sideeffect
occur
recipi
elev
temperatur
occur
gener
popul
vaccin
inactiv
influenza
vaccin
stimul
antibodi
iga
igm
class
right
circumst
also
lead
product
igg
immunoglobulin
blood
depend
great
extent
prevaccin
level
increas
fever
result
synthesi
hsp
also
found
varieti
environment
stressor
includ
vaccin
shortterm
cold
hot
exposur
also
alter
synthesi
total
plasma
ghrelin
concentr
human
ghrelin
block
apoptosi
signalregul
kinas
activ
via
upregul
ghrelin
attenu
burninduc
dysfunct
ghrelin
discov
kojima
et
al
present
two
major
form
tissu
circul
one
bind
fatti
acid
octano
acid
capryl
acid
call
lipopeptid
acyl
ghrelin
contain
fatti
acid
call
desacyl
ghrelin
owe
properti
hypothes
ghrelin
iga
igm
igg
level
could
chang
particularli
condit
fever
immun
circul
level
ghrelin
like
increas
reduc
respect
purpos
studi
measur
circul
level
acyl
desacyl
ghrelin
iga
igm
igg
blood
taken
vaccin
day
month
regardless
fever
develop
determin
associ
clinic
biochem
paramet
healthcar
worker
inocul
swine
flu
concentr
glucos
aspart
aminotransferas
ast
alanin
aminotransferas
alt
gammaglutamyltransferas
ggt
total
cholesterol
triglycerid
low
densiti
lipoprotein
vldl
cholesterol
highdens
lipoprotein
hdl
highdens
lipoproteincholesterol
hdlc
measur
standard
method
certifi
laboratori
low
densiti
lipoprotein
ldl
low
densiti
lipoproteincholesterol
ldlc
calcul
use
friedewald
equat
valu
measur
accord
manufactur
instruct
use
elisa
method
uscn
life
scienc
inc
detect
rang
ngml
serum
sampl
also
assay
acyl
cat
desacyl
ghrelin
cat
use
commerci
avail
elisa
spi
bio
bertin
pharma
biotech
montigni
le
brettoneux
franc
detect
limit
acyl
ghrelin
elisa
pgml
desacyl
ghrelin
pgml
immunoglobulin
iga
g
igg
igm
determin
nephelometr
method
use
siemen
machin
model
bn
ii
sera
analyz
divid
two
group
depend
whether
fever
develop
due
vaccin
statist
analys
conduct
use
spss
packag
softwar
paramet
present
mean
standard
deviat
data
among
group
compar
use
pearson
correl
test
linear
regress
analys
carri
mean
valu
use
pearson
test
p
consid
statist
signific
origin
vaccin
health
worker
n
complet
studi
subject
develop
fever
total
subject
fever
fever
major
subject
drop
studi
develop
fever
vaccin
day
swine
fluvaccinationassoci
fever
disappear
bodi
temperatur
around
accept
normal
even
control
consid
develop
fever
eleven
subject
develop
fever
curiou
result
want
complet
studi
remaind
complet
studi
even
though
show
vaccinationassoci
problem
also
healthi
control
subject
vaccin
demograph
characterist
particip
show
statist
differ
bmi
height
age
none
particip
develop
major
clinic
symptom
month
vaccin
fever
tabl
show
biochem
paramet
studi
feverish
period
fever
alt
ast
ggt
valu
show
littl
chang
ggt
valu
elev
postvaccin
day
month
valu
return
normal
month
ghrelin
valu
blood
sampl
collect
vaccin
control
subject
vaccin
compar
blood
sampl
collect
day
vaccin
handoff
subject
lower
ghrelin
level
month
risen
back
basal
level
ghrelin
level
subject
develop
fever
compar
ghrelin
level
blood
sampl
former
significantli
lower
fever
gener
return
normal
within
day
ghrelin
level
sampl
taken
month
similar
basal
level
control
subject
fig
valu
sampl
taken
vaccin
control
subject
vaccin
compar
postvaccin
day
found
higher
level
blood
sampl
taken
month
fallen
back
basal
level
comparison
level
subject
develop
fever
significantli
elev
compar
fever
serum
hsp
level
fell
back
basal
level
month
fig
immunoglobulin
iga
g
level
compar
basal
level
level
control
group
increas
observ
sampl
time
day
vaccin
fig
natur
infect
vaccin
result
develop
humor
cellular
immun
interferon
product
blood
nasal
secret
analyz
day
vaccin
contain
immunoglobulin
ig
g
igm
iga
class
antibodi
igm
iga
antibodi
disappear
year
igg
antibodi
last
lifetim
serum
igm
iga
igg
level
follow
vaccin
found
investig
increas
significantli
day
month
comparison
igm
iga
igg
antibodi
valu
vaccin
day
vaccin
timedepend
serum
level
igm
iga
igg
level
group
develop
fever
differ
control
prevaccin
valu
lu
et
al
report
system
immun
respiratori
syndrom
coronaviru
sarscov
viruslik
particl
vlp
increas
immunoglobulin
may
play
import
role
protect
viral
infect
timedepend
increas
serum
level
igm
iga
igg
antibodi
vaccin
may
occur
via
bcell
activ
follow
swine
flu
vaccin
therefor
play
import
role
clinic
evalu
followup
also
measur
serum
acyl
desacyl
ghrelin
serum
valu
vaccin
subject
whose
bodi
temperatur
rose
well
valu
subject
whose
bodi
temperatur
compar
control
group
decreas
level
occur
level
time
increas
decreas
ghrelin
level
vaccin
may
result
vaccin
caus
extrem
stress
bodi
ghrelin
use
scaveng
free
radic
ghrelin
natur
endogen
antioxid
bodi
support
serum
ghrelin
level
control
prevaccin
postvaccin
day
month
sampl
level
first
elev
restor
prevaccin
level
signific
decreas
ghrelin
level
associ
fever
consist
result
obtain
tomasik
et
al
kept
subject
environ
vari
temperatur
found
increas
temperatur
result
decreas
ghrelin
level
exogen
variou
hormon
drug
also
affect
ghrelin
concentr
insulin
either
oral
intraven
glucos
somatostatin
cortistatin
suppress
circul
ghrelin
concentr
find
show
serum
ghrelin
level
chang
cold
hot
stress
variou
hormon
drug
ghrelin
level
also
decreas
patient
receiv
interferon
therapi
mean
foreign
substanc
inject
bodi
eg
vaccin
either
directli
suppress
ghrelin
synthesi
appropri
organ
ghrelin
metabol
use
elimin
stress
caus
foreign
substanc
ghrelin
express
inhibit
interferon
gama
elev
serum
patient
develop
fever
associ
vaccin
may
arisen
product
bodi
caus
fever
numer
studi
demonstr
increas
even
slightest
increas
temperatur
manner
bodi
normal
react
fever
argument
support
fact
express
rose
feverish
patient
wherea
preand
postvaccin
valu
patient
develop
fever
remain
evalu
result
consid
limit
follow
person
declin
vaccin
may
differ
unmeasur
way
accept
vaccin
peopl
usual
fast
overnight
vaccin
subject
drop
vaccin
arm
studi
low
threshold
use
fever
averag
normal
temperatur
known
whether
differ
formul
vaccin
yield
differ
result
known
whether
receipt
season
influenza
vaccin
regardless
adjuv
unadjuv
caus
similar
phenomena
vaccin
known
whether
adjuv
contribut
decreas
ghrelin
increas
level
final
known
whether
observ
fever
could
associ
increas
total
antibodi
lead
high
reactogen
sideeffect
conclus
increas
serum
level
igm
iga
igg
seen
patient
vaccin
rel
level
swine
flu
vaccin
control
indic
vaccin
stimul
humor
immun
system
serum
significantli
increas
patient
develop
fever
vaccin
serum
ghrelin
level
fell
significantli
first
month
postvaccin
sampl
decreas
serum
ghrelin
level
mark
patient
develop
fever
level
fall
back
fever
disappear
seen
patient
develop
fever
result
indic
increas
serum
level
igm
iga
igg
level
elev
associ
fever
reduc
ghrelin
level
import
paramet
clinic
evalu
followup
vaccin
find
could
also
use
clinic
preclin
trial
develop
vaccin
less
like
induc
fever
also
provid
inform
whether
rather
intens
blooddraw
schedul
would
seem
rule
use
routin
practic
vaccin
